REGENXBIO announces closing of public offering of common stock and underwriters option
REGENXBIO announced the closing of its underwritten public offering of 2,700,000 shares of its common stock at a price to the public of $65.00 per share, along with the underwriters' option to purchase 405,000 additional shares. Gross proceeds are expected to be $201.8 million. August 14, 2018